Summary of Innovation in Life Sciences

Looking for the report?
We have the summary! Get the key insights in just 5 minutes.

Innovation in Life Sciences summary
Start getting smarter:
or see our plans

Rating

9

Qualities

  • Analytical
  • Scientific
  • Overview

Recommendation

What does it take for a newcomer in the life sciences to catch up to Western European and North American players? According to this well-researched and informative analysis by The Economist Intelligence Unit, the number one requirement is innovation. Established Western players have the know-how, the resources and the experience. To catch up in the pharmaceutical race, emerging players have to find new ways to be innovative. getAbstract recommends this report to innovators in any field interested in advancing their business ventures.

About the Author

The Economist Intelligence Unit is the research and analysis department of The Economist Group.

 

Summary

Developing strong, innovative companies in the life sciences sectors is a challenge due to the scientific expertise and regulations needed. Historically, North American and European companies have had an advantage. However, a few new players such as Brazil, India, China, South Korea, Costa Rica and Singapore are proving that they can also becoming leaders.

Innovation is the secret to success for emerging economies. But, how does a country become innovative in the life sciences sector? Answering that question requires a definition of “innovation. Innovation...


More on this topic

Customers who read this summary also read

Innovation Nation
7
Embracing Innovation in Government
9
How to Maintain America’s Edge
8
The Most Innovative Companies 2016
8
The Dawn of the Deep Tech Ecosystem
9
Wikipedia Is the Last Best Place on the Internet
8

Related Channels

Comment on this summary